Latest period
$126.63M
YoY change
-4.8%
5Y CAGR
+3.0%
Peak year (2019)
$155.22M
Cumulative CapEx
$2.20B
CapEx history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: $124.68M
CapEx growth chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: -4.8%
CapEx history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| 2025 | $124.68M | -4.8% | −$6.25M | ||
| 2024 | $130.92M | -2.0% | −$2.71M | ||
| 2023 | $133.63M | -10.2% | −$15.21M | ||
| 2022 | $148.84M | +24.5% | +$29.29M | ||
| 2021 | $119.55M | +11.1% | +$11.92M | ||
| 2020 | $107.63M | -30.7% | −$47.60M | ||
| 2019 | $155.22M | +26.3% | +$32.29M | ||
| 2018 | $122.94M | +60.3% | +$46.23M | ||
| 2017 | $76.70M | +18.4% | +$11.92M | ||
| 2016 | $64.79M | -21.9% | −$18.13M | ||
| 2015 | $82.92M | +36.6% | +$22.22M | ||
| 2014 | $60.70M | -22.8% | −$17.94M | ||
| 2013 | $78.64M | +13.9% | +$9.59M | ||
| 2012 | $69.05M | -31.1% | −$31.17M | ||
| 2011 | $100.22M | +155.0% | +$60.92M | ||
| 2010 | $39.30M | -32.1% | −$18.54M | ||
| 2009 | $57.84M | -35.7% | −$32.13M | ||
| 2008 | $89.97M | +35.8% | +$23.73M | ||
| 2007 | $66.24M | -7.2% | −$5.11M | ||
| 2006 | $71.36M | +194.9% | +$47.16M | ||
| 2005 | $24.20M | -23.7% | −$7.51M | ||
| 2004 | $31.70M | +87.6% | +$14.81M | ||
| 2003 | $16.90M | +12.0% | +$1.81M | ||
| 2002 | $15.09M | -13.2% | −$2.29M | ||
| 2001 | $17.38M | +12.0% | +$1.86M | ||
| 2000 | $15.52M | +25.2% | +$3.12M | ||
| 1999 | $12.40M | -74.2% | −$35.70M | ||
| 1998 | $48.10M | +35.5% | +$12.60M | ||
| 1997 | $35.50M | +200.8% | +$23.70M | ||
| 1996 | $11.80M | -25.8% | −$4.10M | ||
| 1995 | $15.90M | +261.4% | +$11.50M | ||
| 1994 | $4.40M | +109.5% | +$2.30M | ||
| 1993 | $2.10M | -8.7% | −$200.00K | ||
| 1992 | $2.30M | -75.5% | −$7.10M | ||
| 1991 | $9.40M | — | — |
- 2025$124.68M-4.8%
- 2024$130.92M-2.0%
- 2023$133.63M-10.2%
- 2022$148.84M+24.5%
- 2021$119.55M+11.1%
- 2020$107.63M-30.7%
- 2019$155.22M+26.3%
- 2018$122.94M+60.3%
- 2017$76.70M+18.4%
- 2016$64.79M-21.9%
- 2015$82.92M+36.6%
- 2014$60.70M-22.8%
- 2013$78.64M+13.9%
- 2012$69.05M-31.1%
- 2011$100.22M+155.0%
- 2010$39.30M-32.1%
- 2009$57.84M-35.7%
- 2008$89.97M+35.8%
- 2007$66.24M-7.2%
- 2006$71.36M+194.9%
- 2005$24.20M-23.7%
- 2004$31.70M+87.6%
- 2003$16.90M+12.0%
- 2002$15.09M-13.2%
- 2001$17.38M+12.0%
- 2000$15.52M+25.2%
- 1999$12.40M-74.2%
- 1998$48.10M+35.5%
- 1997$35.50M+200.8%
- 1996$11.80M-25.8%
- 1995$15.90M+261.4%
- 1994$4.40M+109.5%
- 1993$2.10M-8.7%
- 1992$2.30M-75.5%
- 1991$9.40M—
CapEx values are taken from IDEXX Laboratories's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at IDEXX Laboratories (IDXX)
According to IDEXX Laboratories's latest reported financial statements, the company's current CapEx (TTM) is $126.63M. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
IDEXX Laboratories (IDXX) most recent annual CapEx stands at $124.68M (2025) – edged down 4.8% year-over-year.
Over 2020–2025 (5 years), IDEXX Laboratories CapEx expanded at a +3.0% compound annual rate, with mixed annual results across the window.
Between 2019 and 2025, IDEXX Laboratories CapEx declined 19.7%, falling from $155.22M to $124.68M.
The highest annual CapEx of $155.22M was reported in 2019. The lowest in the available history was $2.10M in 1993.
IDEXX Laboratories Capital Expenditures by Year
IDEXX Laboratories Capital Expenditures 2025: $124.68M
2025's CapEx for IDEXX Laboratories came in at $124.68M, edged down 4.8% below 2024.
IDEXX Laboratories Capital Expenditures 2024: $130.92M
IDEXX Laboratories posted CapEx of $130.92M in 2024, edged down 2.0% below 2023.
IDEXX Laboratories Capital Expenditures 2023: $133.63M
In 2023, IDEXX Laboratories reported CapEx of $133.63M, declined 10.2% below 2022.
IDEXX Laboratories Capital Expenditures 2022: $148.84M
IDEXX Laboratories CapEx in 2022 was $148.84M, grew 24.5% from 2021.
IDEXX Laboratories Capital Expenditures 2021: $119.55M
IDEXX Laboratories CapEx in 2021 was $119.55M.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers by CapEx
Healthcare peers of IDEXX Laboratories (IDXX), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
IDEXX Laboratories (IDXX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation